大葉大學圖書館 |

Circulating nucleic acids in early diagnosis, prognosis and treatment monitoring[electronic resource] :an introduction /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.0756
書名/作者:	Circulating nucleic acids in early diagnosis, prognosis and treatment monitoring : an introduction // edited by Peter B. Gahan.
其他作者:	Gahan, Peter B.
出版者:	Dordrecht : : Springer Netherlands :, 2015.
面頁冊數:	xix, 471 p. : : ill. (some col.), digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Nucleic acids - Diagnostic use.
標題:	Biomedicine.
標題:	Biomedicine general.
標題:	Health Promotion and Disease Prevention.
標題:	Cancer Research.
標題:	Nucleic Acid Chemistry.
標題:	Medicinal Chemistry.
ISBN:	9789401791687 (electronic bk.)
ISBN:	9789401791670 (paper)
內容註:	Part I. BACKGROUND -- CHAPTER 1 Introduction - Brief History and the present and future status of CNAPS -- CHAPTER 2 The biology of CNAPS -- Part II. METHODOLOGY -- CHAPTER 3 Pre-analytical requirements for analysing nucleic acids from blood -- CHAPTER 4 Circulating DNA and miRNA isolation -- CHAPTER 5 Detection of genetic alterations by nucleic acid analysis: use of pcr and mass spectroscopy-based methods -- CHAPTER 6 Genomic approaches to the analysis of cell free nucleic acids -- Part III APPLICATIONS -- CHAPTER 7 CNAPS and General Medicine -- CHAPTER 8 Fetal CNAPS DNA/RNA -- CHAPTER 9 Circulating nucleic acids and Diabetes mellitus -- CHAPTER 10 Extracellular nucleic acids and cancer -- CHAPTER 11 Other bodily fluids as non-invasive sources of Cell-free DNA/RNA -- CHAPTER 12 CNAPS in therapy monitoring -- Part IV OTHER ASPECTCS -- CHAPTER 13 Quality Assurance -- CHAPTER 14 Societal Aspects: Ethics.
摘要、提要註:	DNA and RNA fractions can be isolated from a variety of body fluids including whole blood, serum, plasma, urine, saliva and cerebrospinal fluid from both patients and healthy individuals. Such isolates can be exploited in the early detection of clinical disorders, stratification of patients for treatment, treatment monitoring and clinical follow-up. In addition, the use in fetal medicine allows the early detection of fetal sex, Rh factor and aneuploid disorders as well as following both fetal and premature born infant development. This volume is intended as a primer for those who are interested in entering the field of circulating nucleic acids. The areas covered in this volume include: Background and general biology of circulating nucleic acids Methodology Applications of circulating nucleic acids Quality Assurance Ethics
電子資源:	http://dx.doi.org/10.1007/978-94-017-9168-7

Circulating nucleic acids in early diagnosis, prognosis and treatment monitoring[electronic resource] :an introduction /
Circulating nucleic acids in early diagnosis, prognosis and treatment monitoringan introduction /[electronic resource] :edited by Peter B. Gahan. - Dordrecht :Springer Netherlands :2015. - xix, 471 p. :ill. (some col.), digital ;24 cm. - Advances in predictive, preventive and personalised medicine,v.52211-3495 ;. - Advances in predictive, preventive and personalised medicine ;v.1..

Part I. BACKGROUND -- CHAPTER 1 Introduction - Brief History and the present and future status of CNAPS -- CHAPTER 2 The biology of CNAPS -- Part II. METHODOLOGY -- CHAPTER 3 Pre-analytical requirements for analysing nucleic acids from blood -- CHAPTER 4 Circulating DNA and miRNA isolation -- CHAPTER 5 Detection of genetic alterations by nucleic acid analysis: use of pcr and mass spectroscopy-based methods -- CHAPTER 6 Genomic approaches to the analysis of cell free nucleic acids -- Part III APPLICATIONS -- CHAPTER 7 CNAPS and General Medicine -- CHAPTER 8 Fetal CNAPS DNA/RNA -- CHAPTER 9 Circulating nucleic acids and Diabetes mellitus -- CHAPTER 10 Extracellular nucleic acids and cancer -- CHAPTER 11 Other bodily fluids as non-invasive sources of Cell-free DNA/RNA -- CHAPTER 12 CNAPS in therapy monitoring -- Part IV OTHER ASPECTCS -- CHAPTER 13 Quality Assurance -- CHAPTER 14 Societal Aspects: Ethics.

DNA and RNA fractions can be isolated from a variety of body fluids including whole blood, serum, plasma, urine, saliva and cerebrospinal fluid from both patients and healthy individuals. Such isolates can be exploited in the early detection of clinical disorders, stratification of patients for treatment, treatment monitoring and clinical follow-up. In addition, the use in fetal medicine allows the early detection of fetal sex, Rh factor and aneuploid disorders as well as following both fetal and premature born infant development. This volume is intended as a primer for those who are interested in entering the field of circulating nucleic acids. The areas covered in this volume include: Background and general biology of circulating nucleic acids Methodology Applications of circulating nucleic acids Quality Assurance Ethics

ISBN: 9789401791687 (electronic bk.)

Standard No.: 10.1007/978-94-017-9168-7doiSubjects--Topical Terms:

605018
Nucleic acids
--Diagnostic use.

LC Class. No.: RB43.8.N83

Dewey Class. No.: 616.0756

Circulating nucleic acids in early diagnosis, prognosis and treatment monitoring[electronic resource] :an introduction /
LDR:02839nam a2200325 a 4500 001 425733
003 DE-He213
005 20150727135155.0
006 m d
007 cr nn 008maaau
008 151119s2015 ne s 0 eng d
020 $a 9789401791687 (electronic bk.)
020 $a 9789401791670 (paper)
024 7 $a 10.1007/978-94-017-9168-7 $2 doi
035 $a 978-94-017-9168-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RB43.8.N83
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
082 0 4 $a 616.0756 $2 23
090 $a RB43.8.N83 $b C578 2015
245 0 0 $a Circulating nucleic acids in early diagnosis, prognosis and treatment monitoring $h [electronic resource] : $b an introduction / $c edited by Peter B. Gahan.
260 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2015.
300 $a xix, 471 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Advances in predictive, preventive and personalised medicine, $x 2211-3495 ; $v v.5
505 0 $a Part I. BACKGROUND -- CHAPTER 1 Introduction - Brief History and the present and future status of CNAPS -- CHAPTER 2 The biology of CNAPS -- Part II. METHODOLOGY -- CHAPTER 3 Pre-analytical requirements for analysing nucleic acids from blood -- CHAPTER 4 Circulating DNA and miRNA isolation -- CHAPTER 5 Detection of genetic alterations by nucleic acid analysis: use of pcr and mass spectroscopy-based methods -- CHAPTER 6 Genomic approaches to the analysis of cell free nucleic acids -- Part III APPLICATIONS -- CHAPTER 7 CNAPS and General Medicine -- CHAPTER 8 Fetal CNAPS DNA/RNA -- CHAPTER 9 Circulating nucleic acids and Diabetes mellitus -- CHAPTER 10 Extracellular nucleic acids and cancer -- CHAPTER 11 Other bodily fluids as non-invasive sources of Cell-free DNA/RNA -- CHAPTER 12 CNAPS in therapy monitoring -- Part IV OTHER ASPECTCS -- CHAPTER 13 Quality Assurance -- CHAPTER 14 Societal Aspects: Ethics.
520 $a DNA and RNA fractions can be isolated from a variety of body fluids including whole blood, serum, plasma, urine, saliva and cerebrospinal fluid from both patients and healthy individuals. Such isolates can be exploited in the early detection of clinical disorders, stratification of patients for treatment, treatment monitoring and clinical follow-up. In addition, the use in fetal medicine allows the early detection of fetal sex, Rh factor and aneuploid disorders as well as following both fetal and premature born infant development. This volume is intended as a primer for those who are interested in entering the field of circulating nucleic acids. The areas covered in this volume include: Background and general biology of circulating nucleic acids Methodology Applications of circulating nucleic acids Quality Assurance Ethics
650 0 $a Nucleic acids $x Diagnostic use. $3 605018
650 1 4 $a Biomedicine. $3 463454
650 2 4 $a Biomedicine general. $3 463541
650 2 4 $a Health Promotion and Disease Prevention. $3 463648
650 2 4 $a Cancer Research. $3 463530
650 2 4 $a Nucleic Acid Chemistry. $3 466899
650 2 4 $a Medicinal Chemistry. $3 463754
700 1 $a Gahan, Peter B. $3 605017
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Advances in predictive, preventive and personalised medicine ; $v v.1. $3 490642
856 4 0 $u http://dx.doi.org/10.1007/978-94-017-9168-7
950 $a Medicine (Springer-11650)